Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Lilly's Zepbound tops Wegovy for weight loss
Eli Lilly’s Zepbound Beats Novo Nordisk’s Wegovy in First Head-to-Head Study
People who took Zepbound lost 17 pounds more on average after 72 weeks of treatment than those who were given Novo Nordisk’s drug.
Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial
Eli Lilly's popular weight-loss drug Zepbound outperformed Danish drugmaker Novo Nordisk's Wegovy in a clinical trial, according results of the study released Wednesday.
Lilly’s Zepbound Beats Novo’s Wegovy in Head-to-Head Trial
Eli Lilly & Co. said its weight-loss drug Zepbound outperformed rival Novo Nordisk A/S’s Wegovy in the first head-to-head trial of the two blockbusters.
Novavax to sell Czech manufacturing unit to Novo Nordisk
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million
By Gnaneshwar Rajan and Maggie Fick (Reuters) -U.S.-based vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in the Czech Republic to Wegovy maker Novo Nordisk for $200 million and use the proceeds for its vaccine pipeline.
Wegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 Million
Novavax sells Czech manufacturing facility to Novo Nordisk for $200 million, aiming to cut costs by $80 million annually and support its growth strategy.
Novavax to sell Czech Republic manufacturing facility to Novo Nordisk for $200M
Novavax (NVAX) announced that it has signed a definitive agreement to sell its manufacturing facility in Bohumil, Czech Republic to Novo
STAT
20h
Pharmalittle: We’re reading about a Zepbound-Wegovy faceoff, compounders slamming Novo, and more
Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo ...
globalconstructionreview
20h
Wegovy-maker Novo Nordisk to build €390m quality control centre
Novo Nordisk, the Danish company that makes diabetes drug Ozempic and obesity treatment Wegovy, has begun work on a 5.3ha ...
The Cincinnati Enquirer
4d
Why your co-pay for weight loss drugs like Wegovy just went through the roof
For Debbie Halstead, the weight loss medication
Wegovy
has been nothing short of a miracle. The Cool Ridge, West Virginia, ...
STAT
1d
Pharmalittle: We’re reading about menopause treatments, Novo plans for Wegovy in India, and more
Yet at the annual meeting of the Menopause Society earlier this fall, researchers presented new evidence that hormone therapy ...
devdiscourse
2d
Novo Nordisk Races to Launch Wegovy in India Amid Competitive Pressures
Novo Nordisk is working to accelerate the launch of its weight-loss drug Wegovy in India, concerned about lagging behind Eli ...
1d
Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum
Defiance ETFs introduces NVOX, a leveraged ETF offering 2X exposure to Novo Nordisk's stock price movements, targeting the ...
GlobalData on MSN
6d
Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks
Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial ...
4d
on MSN
Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback